CTOs on the Move

Willis-Knighton Health System

www.wkhs.com

 
Willis-Knighton Health System, headquartered in Shreveport, Louisiana, is a not-for-profit community healthcare corporation with four general acute care hospitals and affiliate relationships with several rural hospitals. It is the largest nongovernmental employer in the region, employing more than 6,500 people.
  • Number of Employees: 1K-5K
  • Annual Revenue: $250-500 Million
  • www.wkhs.com
  • 2600 Greenwood Rd
    Shreveport, LA USA 71103
  • Phone: 318.212.4000

Executives

Name Title Contact Details

Similar Companies

Primus Pharmaceuticals

Primus Pharmaceuticals, Inc is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Primus Pharmaceuticals, Inc is based in Scottsdale, AZ. You can find more information on Primus Pharmaceuticals, Inc at www.primusrx.com

Abc For Health

Abc For Health is a Madison, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Pharmacy Insurance Corporation of America - PICA

Pharmacy Insurance Corporation of America - PICA is a San Juan, PR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nutex Health

The Future of Healthcare Nutex Health Inc. is a technology-enabled health management company with two divisions: Business Development Marketing Operations Coordination Legal Human Resources Accounting Billing & Collections Nutex Health Inc. is a techno...

Immune Pharmaceuticals

Immune Pharmaceuticals applies a personalized approach to treatment, developing novel, highly targeted antibody therapeutics to improve the lives of patients with inflammatory diseases and cancer. The Company’s lead product candidate, bertilimumab, is entering Phase II clinical studies for moderate-to-severe ulcerative colitis and bullous pemphigoid, with additional studies planned for Crohn’s disease and severe asthma. The Company is evaluating the use of its NanomAb® platform, a second generation antibody drug conjugate technology, with chemotherapeutics in order to enhance their safety and efficacy profiles by delivering the medicines directly to cancer cells. The Company’s growing oncology pipeline also includes proprietary antibodies and, clinical-stage small molecules that have been shown activity in a variety of solid tumors. Immune is headquartered in the U.S., with its primary research and development facilities in Israel.